Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

ProteoDesign

ProteoDesign
2012 FOUNDED
PRIVATE STATUS
Early Stage VC LATEST DEAL TYPE
$2.01M LATEST DEAL AMOUNT
5 INVESTORS
Description

Developer of new generation of protein therapeutics designed to treat cancer. The company's new generation of protein therapeutics uses proprietary conjugation technologies that helps in the development and production of a superior class of bio-therapeutics, including antibody-drug conjugates, overcoming limitations of the currently used methods, enabling biotech companies to develop better biological drugs and to improve patients' quality of life.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Primary Office
  • Parc Científic de Barcelona (PCB)
  • Baldiri Reixac, 10-12
  • 08028 Barcelona
  • Spain

+34 934 00 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore ProteoDesign’s full profile, request a free trial.

ProteoDesign Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 12-Dec-2017 $2.01M 00.000 Completed Generating Revenue
3. Grant 28-Nov-2015 Completed Generating Revenue
2. Early Stage VC 20-Apr-2015 Completed Generating Revenue
1. Seed Round 13-Jan-2014 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

ProteoDesign Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
ACC1O Government 000 0000 000000 0
Empresa Nacional de Innovación Venture Capital Minority 000 0000 000000 0
European Union Government 000 0000 000000 0
Spanish Ministry of Foreign Affairs and Cooperation Government 000 0000 000000 0
Caixa Capital Risc Corporate Venture Capital Minority 000 0000 000000 0

ProteoDesign Executive Team (5)

Name Title Board
Seat
Contact
Info
Silvia Frutos Ph.D Co-Founder & Chief Operations Officer
Miquel Vila-Perelló Ph.D Co-Founder, Managing Director and Chief Science Officer
Thomas Muir Ph.D Co-Founder & Scientific Advisor
Marc Litchfield Co-Founder & Board Member
Gerard Caelles Manager, Business Development

ProteoDesign Board Members (4)

Name Representing Role Since Contact
Info
Alex Casta Ruiz Ph.D ProteoDesign Board Member 000 0000
Jose Antonio Mesa Cejudo ProteoDesign Board Member 000 0000
Marc Litchfield ProteoDesign Co-Founder & Board Member 000 0000
William Middlekauff ProteoDesign Board Member 000 0000